KONINKLIJKE PHILIPS NV (PHIA.AS) Fundamental Analysis & Valuation

AMS:PHIA • NL0000009538

Current stock price

24.58 EUR
+0.11 (+0.45%)
Last:

This PHIA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. PHIA.AS Profitability Analysis

1.1 Basic Checks

  • PHIA had positive earnings in the past year.
  • PHIA had a positive operating cash flow in the past year.
  • In multiple years PHIA reported negative net income over the last 5 years.
  • Of the past 5 years PHIA 4 years had a positive operating cash flow.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • PHIA has a Return On Assets (3.32%) which is in line with its industry peers.
  • With a decent Return On Equity value of 8.17%, PHIA is doing good in the industry, outperforming 60.32% of the companies in the same industry.
  • PHIA has a Return On Invested Capital (5.50%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PHIA is significantly below the industry average of 9.72%.
  • The last Return On Invested Capital (5.50%) for PHIA is above the 3 year average (3.48%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.5%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • With a Profit Margin value of 5.02%, PHIA perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
  • PHIA's Profit Margin has declined in the last couple of years.
  • PHIA's Operating Margin of 7.98% is in line compared to the rest of the industry. PHIA outperforms 42.86% of its industry peers.
  • In the last couple of years the Operating Margin of PHIA has declined.
  • The Gross Margin of PHIA (45.18%) is worse than 76.19% of its industry peers.
  • In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PHIA.AS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHIA is destroying value.
  • Compared to 1 year ago, PHIA has more shares outstanding
  • PHIA has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for PHIA is higher compared to a year ago.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • PHIA has an Altman-Z score of 2.01. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • PHIA has a Altman-Z score of 2.01. This is comparable to the rest of the industry: PHIA outperforms 41.27% of its industry peers.
  • The Debt to FCF ratio of PHIA is 16.37, which is on the high side as it means it would take PHIA, 16.37 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 16.37, PHIA is in line with its industry, outperforming 41.27% of the companies in the same industry.
  • PHIA has a Debt/Equity ratio of 0.63. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
  • PHIA's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. PHIA is outperformed by 65.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z 2.01
ROIC/WACC0.87
WACC6.29%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that PHIA should not have too much problems paying its short term obligations.
  • The Current ratio of PHIA (1.32) is comparable to the rest of the industry.
  • PHIA has a Quick Ratio of 1.32. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PHIA has a Quick ratio of 0.94. This is in the lower half of the industry: PHIA underperforms 60.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PHIA.AS Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.11% over the past year.
  • PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.62% yearly.
  • The Revenue has decreased by -1.03% in the past year.
  • The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.24% on average over the next years. This is quite good.
  • Based on estimates for the next years, PHIA will show a small growth in Revenue. The Revenue will grow by 3.78% on average per year.
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue Next Year1.29%
Revenue Next 2Y2.83%
Revenue Next 3Y3.44%
Revenue Next 5Y3.78%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. PHIA.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • PHIA is valuated correctly with a Price/Earnings ratio of 16.72.
  • PHIA's Price/Earnings ratio is rather cheap when compared to the industry. PHIA is cheaper than 80.95% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.11, PHIA is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 16.07, which indicates a correct valuation of PHIA.
  • 65.08% of the companies in the same industry are more expensive than PHIA, based on the Price/Forward Earnings ratio.
  • PHIA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.72
Fwd PE 16.07
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • PHIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 69.84% of the companies in the same industry.
  • PHIA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 47.91
EV/EBITDA 11.32
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.14
PEG (5Y)N/A
EPS Next 2Y8.35%
EPS Next 3Y10.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHIA.AS Dividend Analysis

5.1 Amount

  • PHIA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHIA.AS Fundamentals: All Metrics, Ratios and Statistics

KONINKLIJKE PHILIPS NV

AMS:PHIA (3/17/2026, 7:00:00 PM)

24.58

+0.11 (+0.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners47.46%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.67B
Revenue(TTM)17.84B
Net Income(TTM)895.00M
Analysts75.33
Price Target29.32 (19.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.35
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)7.51%
PT rev (3m)6.07%
EPS NQ rev (1m)-20.3%
EPS NQ rev (3m)-14.31%
EPS NY rev (1m)0.51%
EPS NY rev (3m)-0.9%
Revenue NQ rev (1m)2.87%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-2.05%
Valuation
Industry RankSector Rank
PE 16.72
Fwd PE 16.07
P/S 1.33
P/FCF 47.91
P/OCF 20.37
P/B 2.16
P/tB N/A
EV/EBITDA 11.32
EPS(TTM)1.47
EY5.98%
EPS(NY)1.53
Fwd EY6.22%
FCF(TTM)0.51
FCFY2.09%
OCF(TTM)1.21
OCFY4.91%
SpS18.52
BVpS11.38
TBVpS-0.92
PEG (NY)4.14
PEG (5Y)N/A
Graham Number19.4
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.5%
ROICexc 6.42%
ROICexgc 22.25%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
ROICexc(3y)3.99%
ROICexc(5y)N/A
ROICexgc(3y)13.73%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.19%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.56%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z 2.01
F-Score7
WACC6.29%
ROIC/WACC0.87
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.29%
Revenue Next 2Y2.83%
Revenue Next 3Y3.44%
Revenue Next 5Y3.78%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-4.71%
EBIT Next Year68.67%
EBIT Next 3Y26.47%
EBIT Next 5Y17.86%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NV / PHIA.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?

ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.


What is the valuation status of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NV?

KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 4 / 10.


How financially healthy is KONINKLIJKE PHILIPS NV?

The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.


Can you provide the dividend sustainability for PHIA stock?

The dividend rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 0 / 10 and the dividend payout ratio is 36.65%.